The national congress of the Italian Association of Medical Oncology (Aiom) in Rome highlighted the issues of equitable access to cancer therapies in Italy, with waiting times of up to 400 days for new treatments and a fund for innovative drugs not fully utilized, calling for a governance model that eliminates bureaucratic obstacles to ensure all patients have immediate access to therapeutic innovations. #EquitàInSalute #Oncologia #InnovazioneFarmaceutica (translated)
